Cohort Of Cancer Patients No Reported Covid Cases - All Were Taking Methylene Blue

Discussion in 'Methylene Blue' started by High_Prob, Apr 5, 2020.

  1. High_Prob

    High_Prob Member

    Joined:
    Mar 23, 2016
    Messages:
    300
    Gender:
    Male
    EDIT: Just realized that Mito posted this already...

    A cohort of cancer patients with no reported cases of SARS-CoV-2 infection : the possible preventive role of Methylene Blue — Guérir du Cancer

    A COHORT OF CANCER PATIENTS WITH NO REPORTED CASES OF SARS-COV-2 INFECTION : THE POSSIBLE PREVENTIVE ROLE OF METHYLENE BLUE
    Abstract

    We report the case of a cohort of 2500 French patients treated among others with methylene blue for cancer care. During the COVID-19 epidemics none of them developed influenza-like illness. Albeit this lack of infection might be by chance alone, it is possible that methylene blue might have a preventive effect for COVID-19 infection. This is in line with the antiviral activity of Chloroquine, a Methylene blue derivative.

    Both Chloroquine and Methylene blue have strong antiviral and anti- inflammatory properties probably linked to the change in intracellular pH and redox state.

    Keywords: COVID-19, cancer, methylene blue, metabolic treatment

    Introduction

    Europe has been recently been hit by an epidemic of COVID-19. We report a cohort of patients treated for cancer in France. This cohort is managed by an association (Espoir Metabolique) and is a cancer support group. There are 2500 patients all at high risk for sepsis because of concomitant chemotherapy. One of us has interviewed (by telephone and by e mail) these patients to register the cases of COVID-19. As of March 27th, 2020, there were no cases of registered COVID-19 or of flu–like syndroms. These patients were treated by a combination of standard therapy and α-lipoic acid (800 mg twice a day), hydroxycitrate (500 mg three times a day) and methylene blue (75 mg three times a day) as well as a low carb diet.

    There were 52% women against 48% men. The most prevalent cancer type were breast cancer (40 %), lung (20%), prostate (10%), uterine (10%), colon (8%), liver (6%) miscellaneous (6%). Albeit this lack of influenza-like illness might be by chance alone, it is possible that one of these molecule might have prevented viral infection. Herein, we present a short scientific survey of what is currently known about the SARS-Cov-2 virus, hydroxychloroquine treatment as well as biochemical properties of methylene blue that was called once upon a time a “magic bullet” for healing a wide range of diseases.

    Background



     
Loading...